AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
REOXYGENATION OF HYPOXIC HUVECS IN HUMAN SERA AUGMENTS NUCLEAR NF-KAPPA-B TRANSLOCATION AND EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1(VCAM-1) - INHIBITION WITH ANTI-HUMAN C5 THERAPY
Authors: COLLARD CD AGAH A MORSE DS ROLLINS SA MATIS LA STAHL GL
Citation: Cd. Collard et al., REOXYGENATION OF HYPOXIC HUVECS IN HUMAN SERA AUGMENTS NUCLEAR NF-KAPPA-B TRANSLOCATION AND EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1(VCAM-1) - INHIBITION WITH ANTI-HUMAN C5 THERAPY, Molecular immunology, 35(6-7), 1998, pp. 20-20
ANTI-C5 SINGLE-CHAIN ANTIBODY THERAPY BLOCKS COMPLEMENT AND LEUKOCYTEACTIVATION AND REDUCES MYOCARDIAL TISSUE-DAMAGE IN CPB PATIENTS
Authors: ROLLINS SA FITCH JCK SHERNAN S RINDER CS RINDER HM SMITH BR COLLARD CD STAHL GL ALFORD BL LI L MATIS LA
Citation: Sa. Rollins et al., ANTI-C5 SINGLE-CHAIN ANTIBODY THERAPY BLOCKS COMPLEMENT AND LEUKOCYTEACTIVATION AND REDUCES MYOCARDIAL TISSUE-DAMAGE IN CPB PATIENTS, Molecular immunology, 35(6-7), 1998, pp. 266-266
MYOCARDIAL-INFARCTION AND APOPTOSIS AFTER MYOCARDIAL-ISCHEMIA AND REPERFUSION - ROLE OF THE TERMINAL COMPLEMENT COMPONENTS AND INHIBITION BY ANTI-C5 THERAPY
Authors: VAKEVA AP AGAH A ROLLINS SA MATIS LA LI L STAHL GL
Citation: Ap. Vakeva et al., MYOCARDIAL-INFARCTION AND APOPTOSIS AFTER MYOCARDIAL-ISCHEMIA AND REPERFUSION - ROLE OF THE TERMINAL COMPLEMENT COMPONENTS AND INHIBITION BY ANTI-C5 THERAPY, Circulation, 97(22), 1998, pp. 2259-2267
SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS
Authors: FITCH JCK ELEFTERIADES JA MATIS LA EVANS MJ RINDER HM ROLLINS SA ALFORD BL HINES RL
Citation: Jck. Fitch et al., SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS, Journal of the American College of Cardiology, 29(2), 1997, pp. 28169-28169
MONOCLONAL-ANTIBODY TO C5 INHIBITS C5A AND C5B-9 GENERATION WITHOUT INHIBITION OF C3 CLEAVAGE AND SIGNIFICANTLY LIMITS MYOCARDIAL-ISCHEMIA AND REPERFUSION-INDUCED TISSUE-DAMAGE
Authors: VAKEVA A ROLLINS SA MATIS LA STAHL GL
Citation: A. Vakeva et al., MONOCLONAL-ANTIBODY TO C5 INHIBITS C5A AND C5B-9 GENERATION WITHOUT INHIBITION OF C3 CLEAVAGE AND SIGNIFICANTLY LIMITS MYOCARDIAL-ISCHEMIA AND REPERFUSION-INDUCED TISSUE-DAMAGE, Journal of the American College of Cardiology, 29(2), 1997, pp. 98896-98896
RETROVIRAL VECTOR PRODUCER CELL-KILLING IN HUMAN SERUM IS MEDIATED BYNATURAL ANTIBODY AND COMPLEMENT - STRATEGIES FOR EVADING THE HUMORAL IMMUNE-RESPONSE
Authors: ROLLINS SA BIRKS CW SETTER E SQUINTO SP ROTHER RP
Citation: Sa. Rollins et al., RETROVIRAL VECTOR PRODUCER CELL-KILLING IN HUMAN SERUM IS MEDIATED BYNATURAL ANTIBODY AND COMPLEMENT - STRATEGIES FOR EVADING THE HUMORAL IMMUNE-RESPONSE, Human gene therapy, 7(5), 1996, pp. 619-626
REDUCTION OF THE MAJOR PORCINE XENOANTIGEN GA1-ALPHA(1,3)GAL BY EXPRESSION OF ALPHA(1,2)FUCOSYLTRANSFERASE
Authors: SANDRIN MS FODOR WL COHNEY S MOUHTOURIS E OSMAN N ROLLINS SA SQUINTO SP MCKENZIE IFC
Citation: Ms. Sandrin et al., REDUCTION OF THE MAJOR PORCINE XENOANTIGEN GA1-ALPHA(1,3)GAL BY EXPRESSION OF ALPHA(1,2)FUCOSYLTRANSFERASE, Xenotransplantation, 3(1), 1996, pp. 134-140
INHIBITION OF COMPLEMENT ACTIVITY BY HUMANIZED ANTI-C5 ANTIBODY AND SINGLE-CHAIN FV
Authors: THOMAS TC ROLLINS SA ROTHER RP GIANNONI MA HARTMAN SL ELLIOTT EA NYE SH MATIS LA SQUINTO SP EVANS MJ
Citation: Tc. Thomas et al., INHIBITION OF COMPLEMENT ACTIVITY BY HUMANIZED ANTI-C5 ANTIBODY AND SINGLE-CHAIN FV, Molecular immunology, 33(17-18), 1996, pp. 1389-1401
EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX-VIVO XENOGENEIC PERFUSION MODEL
Authors: KROSHUS TJ BOLMAN RM DALMASSO AP ROLLINS SA GUILMETTE ER WILLIAMS BL SQUINTO SP FODOR WL
Citation: Tj. Kroshus et al., EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX-VIVO XENOGENEIC PERFUSION MODEL, Transplantation, 61(10), 1996, pp. 1513-1521
AMELIORATION OF LUPUS-LIKE AUTOIMMUNE-DISEASE IN NZB WF1 MICE AFTER TREATMENT WITH A BLOCKING MONOCLONAL-ANTIBODY SPECIFIC FOR COMPLEMENT COMPONENT C5/
Authors: WANG Y HU QL MADRI JA ROLLINS SA CHODERA A MATIS LA
Citation: Y. Wang et al., AMELIORATION OF LUPUS-LIKE AUTOIMMUNE-DISEASE IN NZB WF1 MICE AFTER TREATMENT WITH A BLOCKING MONOCLONAL-ANTIBODY SPECIFIC FOR COMPLEMENT COMPONENT C5/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(16), 1996, pp. 8563-8568
SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS
Authors: FITCH JCK ELEFTERIADES JA RINDER JM MATIS LA EVANS MJ ROLLINS SA ALFORD BL HINES RL
Citation: Jck. Fitch et al., SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS, Blood, 88(10), 1996, pp. 2603-2603
COMPLEMENT SPECIFIC ANTIBODIES - DESIGNING NOVEL ANTIINFLAMMATORIES
Authors: MATIS LA ROLLINS SA
Citation: La. Matis et Sa. Rollins, COMPLEMENT SPECIFIC ANTIBODIES - DESIGNING NOVEL ANTIINFLAMMATORIES, Nature medicine, 1(8), 1995, pp. 839-842
ENZYMATIC REMODELING OF THE CARBOHYDRATE SURFACE OF A XENOGENIC CELL SUBSTANTIALLY REDUCES HUMAN-ANTIBODY BINDING AND COMPLEMENT-MEDIATED CYTOLYSIS
Authors: SANDRIN MS FODOR WL MOUHTOURIS E OSMAN N COHNEY S ROLLINS SA GUILMETTE ER SETTER E SQUINTO SP MCKENZIE IFC
Citation: Ms. Sandrin et al., ENZYMATIC REMODELING OF THE CARBOHYDRATE SURFACE OF A XENOGENIC CELL SUBSTANTIALLY REDUCES HUMAN-ANTIBODY BINDING AND COMPLEMENT-MEDIATED CYTOLYSIS, Nature medicine, 1(12), 1995, pp. 1261-1267
PROTECTION OF RETROVIRAL VECTOR PARTICLES IN HUMAN BLOOD THROUGH COMPLEMENT INHIBITION
Authors: ROTHER RP SQUINTO SP MASON JM ROLLINS SA
Citation: Rp. Rother et al., PROTECTION OF RETROVIRAL VECTOR PARTICLES IN HUMAN BLOOD THROUGH COMPLEMENT INHIBITION, Human gene therapy, 6(4), 1995, pp. 429-435
PROTECTION OF RETROVIRAL VECTOR PARTICLES VIA COMPLEMENT INHIBITION -A NOVEL STRATEGY FOR IN-VIVO GENE-THERAPY
Authors: ROLLINS SA SQUINTO SP MASON JM ROTHER RP
Citation: Sa. Rollins et al., PROTECTION OF RETROVIRAL VECTOR PARTICLES VIA COMPLEMENT INHIBITION -A NOVEL STRATEGY FOR IN-VIVO GENE-THERAPY, Journal of cellular biochemistry, 1995, pp. 413-413
ANTIBODY-DEPENDENT INACTIVATION OF RETROVIRAL VECTOR PARTICLES BY HUMAN SERUM MEDIATED BY ANTI-ALPHA-GALACTOSYL NATURAL ANTIBODY
Authors: ROTHER RP SPRINGHORN JP FODO WL SQUINTO SP ROLLINS SA
Citation: Rp. Rother et al., ANTIBODY-DEPENDENT INACTIVATION OF RETROVIRAL VECTOR PARTICLES BY HUMAN SERUM MEDIATED BY ANTI-ALPHA-GALACTOSYL NATURAL ANTIBODY, Journal of cellular biochemistry, 1995, pp. 414-414
INJECTABLE RETROVIRAL PARTICLES FOR HUMAN GENE-THERAPY
Authors: SQUINTO SP ROLLINS SA SPRINGHORN JP FODOR WL ROTHER RP
Citation: Sp. Squinto et al., INJECTABLE RETROVIRAL PARTICLES FOR HUMAN GENE-THERAPY, Advanced drug delivery reviews, 17(3), 1995, pp. 213-226
IN-VITRO AND IN-VIVO INHIBITION OF COMPLEMENT ACTIVITY BY A SINGLE-CHAIN FV FRAGMENT RECOGNIZING HUMAN C5
Authors: EVANS MJ ROLLINS SA WOLFF DW ROTHER RP NORIN AJ THERRIEN DM GRIJALVA GA MUELLER JP NYE SH SQUINTO SP WILKINS JA
Citation: Mj. Evans et al., IN-VITRO AND IN-VIVO INHIBITION OF COMPLEMENT ACTIVITY BY A SINGLE-CHAIN FV FRAGMENT RECOGNIZING HUMAN C5, Molecular immunology, 32(16), 1995, pp. 1183-1195
PRIMATE TERMINAL COMPLEMENT INHIBITOR HOMOLOGS OF HUMAN CD59
Authors: FODOR WL ROLLINS SA BIANCOCARON S BURTON WV GUILMETTE ER ROTHER RP ZAVOICO GB SQUINTO SP
Citation: Wl. Fodor et al., PRIMATE TERMINAL COMPLEMENT INHIBITOR HOMOLOGS OF HUMAN CD59, Immunogenetics, 41(1), 1995, pp. 51-51
COMPLEMENT INHIBITION WITH AN ANTI-C5 MONOCLONAL-ANTIBODY PREVENTS ACUTE CARDIAC TISSUE-INJURY IN AN EX-VIVO MODEL OF PIG-TO-HUMAN XENOTRANSPLANTATION
Authors: KROSHUS TJ ROLLINS SA DALMASSO AP ELLIOTT EA MATIS LA SQUINTO SP BOLMAN RM
Citation: Tj. Kroshus et al., COMPLEMENT INHIBITION WITH AN ANTI-C5 MONOCLONAL-ANTIBODY PREVENTS ACUTE CARDIAC TISSUE-INJURY IN AN EX-VIVO MODEL OF PIG-TO-HUMAN XENOTRANSPLANTATION, Transplantation, 60(11), 1995, pp. 1194-1202
MONOCLONAL-ANTIBODIES DIRECTED AGAINST HUMAN C5 AND C8 BLOCK COMPLEMENT-MEDIATED DAMAGE OF XENOGENEIC CELLS AND ORGANS
Authors: ROLLINS SA MATIS LA SPRINGHORN JP SETTER E WOLFF DW
Citation: Sa. Rollins et al., MONOCLONAL-ANTIBODIES DIRECTED AGAINST HUMAN C5 AND C8 BLOCK COMPLEMENT-MEDIATED DAMAGE OF XENOGENEIC CELLS AND ORGANS, Transplantation, 60(11), 1995, pp. 1284-1292
ANTI-C5 MONOCLONAL-ANTIBODY THERAPY PREVENTS COLLAGEN-INDUCED ARTHRITIS AND AMELIORATES ESTABLISHED DISEASE
Authors: WANG Y ROLLINS SA MADRI JA MATIS LA
Citation: Y. Wang et al., ANTI-C5 MONOCLONAL-ANTIBODY THERAPY PREVENTS COLLAGEN-INDUCED ARTHRITIS AND AMELIORATES ESTABLISHED DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(19), 1995, pp. 8955-8959
THE COMPLEMENT CONTROL PROTEIN HOMOLOG OF HERPESVIRUS SAIMIRI REGULATES SERUM COMPLEMENT BY INHIBITING C3 CONVERTASE ACTIVITY
Authors: FODOR WL ROLLINS SA BIANCOCARON S ROTHER RP GUILMETTE ER BURTON WV ALBRECHT JC FLECKENSTEIN B SQUINTO SP
Citation: Wl. Fodor et al., THE COMPLEMENT CONTROL PROTEIN HOMOLOG OF HERPESVIRUS SAIMIRI REGULATES SERUM COMPLEMENT BY INHIBITING C3 CONVERTASE ACTIVITY, Journal of virology, 69(6), 1995, pp. 3889-3892
A NOVEL BIFUNCTIONAL CHIMERIC COMPLEMENT INHIBITOR THAT REGULATES C3 CONVERTASE AND FORMATION OF THE MEMBRANE ATTACK COMPLEX
Authors: FODOR WL ROLLINS SA GUILMETTE ER SETTER E SQUINTO SP
Citation: Wl. Fodor et al., A NOVEL BIFUNCTIONAL CHIMERIC COMPLEMENT INHIBITOR THAT REGULATES C3 CONVERTASE AND FORMATION OF THE MEMBRANE ATTACK COMPLEX, The Journal of immunology, 155(9), 1995, pp. 4135-4138
RAPID EXPRESSION OF AN ANTI-HUMAN C5 CHIMERIC FAB UTILIZING A VECTOR THAT REPLICATES IN COS AND 293 CELLS
Authors: EVANS MJ HARTMAN SL WOLFF DW ROLLINS SA SQUINTO SP
Citation: Mj. Evans et al., RAPID EXPRESSION OF AN ANTI-HUMAN C5 CHIMERIC FAB UTILIZING A VECTOR THAT REPLICATES IN COS AND 293 CELLS, Journal of immunological methods, 184(1), 1995, pp. 123-138
Risultati: 1-25 | 26-38